Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-282-8 | CAS number: 68955-56-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: Read-across to long-chain primary alkyl amines of which toxicity is expected to be comparable (with respect to local effects) to higher (with respect to systemic toxicity due to lower absorption) compared to Dimerdiamine. The acute oral LD50 of Hydrogenated tallow > 5000 mg/kg bw.
A 14-day study for Dimerdiamine at 1000 mg/kg bw/day lead to the mortality of 2/6 animals, and in view of the large difference between acute dose levels and repeated dose levels leading to toxicity, an oral LD50 > 2000 mg/kg bw can also be expected for Dimerdiamine.
There is no information available on acute toxicity via inhalation.
Acute dermal toxicity: Read-across to Coco-alkylamine with an LD50 > 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Pemberley Rabbits, Cottenham, Cambridgeshire
- Age at study initiation: 9 to 10 weeks
- Weight at study initiation: 2.0 to 2.2 kg
- Housing: individual housing in metal cages
- Diet (e.g. ad libitum): SDS Standard Rabbit Diet; ad libitum
- Water (e.g. ad libitum): tap water; ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): approx. 19
- Humidity (%): 30 - 70
- Air changes (per hr): approx. 19
- Photoperiod (hrs dark / hrs light): 12/12 (19:00-7:00 / 7:00-19:00) - Route of administration:
- oral: gavage
- Vehicle:
- other: methyl cellulose
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50 % (w/v) suspension in 1% methyl cellulose
MAXIMUM DOSE VOLUME APPLIED: 10 mL - Doses:
- 5000 mg/kg body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical observations daily; weighing on day 1, 8 and 15
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities throughout study
- Clinical signs:
- other: Pilo-erection, hunched posture, diarrhoea
- Gross pathology:
- no abnormal findings
- Other findings:
- no abnormal findings
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- Based on the findings of this limit test, the acute median lethal dose (LD 50) of Hydrogenated tallow alkyl amine after a single dose to rats was greater than 5000 mg/kg body weight
- Executive summary:
In an GLP compliant OECD TG 401 study, the test material Hydrogenated tallow alkyl amine, a white granular solid (purity 95%), was orally applied to Wistar rats at a dose of 5000 mg/kg bw. The substance was applied as a 50% suspension in 1% methylcellulose (limit-test). There were no deaths, hence, the LD50 exceeded 5000 mg/kg. Clinical signs were diarrhea, piloerection, hunched posture, abnormal gait and pallor of extremities. Complete recovery from these clinical signs was observed by day 5. Body weights were initially reduced but body weight gain was not different from controls by the end of the study (day 15). No treatment-related effects were observed at necropsy. Based on the findings of this study, the acute median lethal dose (LD 50) of Hydrogenated tallow alkyl amine after a single dose to rats was greater than 5000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Although basically based on cross-reading, the overall weight of evidence leads to a well acceptable conclusion for non-classification of C36-alkylenediamine (Dimerdiamine).
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP study similar to Guideline but only 4 animals (2 males/2females) per dose group used
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- only 4 animals per dose group used
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: CFY
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Interfauna UK Limited, Huntingdon, Cambridgeshire, UK
- Age at study initiation: approx. 6 - 8 weeks
- Weight at study initiation: 200 - 245 g - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- The compound was administered either unchanged at a volume of 0.63 mL/kg (= 500 mg/kg) or in water at a volume of 5 mL/kg (=2000 mg/kg).
Since the compound is described as corrosive and dermal irritative reactions were noted in the 500 mg/kg group (undiluted test material), dilution
for testing of the acute dermal toxicity at 2000 mg/kg bw is justifiable.
TEST SITE
- Area of exposure: 10% of total body surface
- % coverage: 100
- Type of wrap if used: occlusive dressing
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.63 ml/kg (undiluted, 500 mg/kg group); 5 ml/kg (40% solution, 2000 mg/kg group)
- Concentration (if solution): 40% in water (only for 2000 mg/kg dose group)
VEHICLE
- water (only for 2000 mg/kg dose group) - Duration of exposure:
- 24h
- Doses:
- 500 mg/kg bw (undiluted)
2000 mg/kg bw (diluted to 40% w/v in water) - No. of animals per sex per dose:
- 2
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No deaths occured during the study.
- Clinical signs:
- other: 500 mg/kg/bw: no clinical signs throughout observation period 2000 mg/kg/bw: hunched posture, abnormal gait (waddling), lethargy, and decreased respiratory rate (shortly after treatment, free of symptoms thereafter)
- Gross pathology:
- Terminal autopsy revealed slight bruising in the subcutaneous tissue of one male and one female rat dosed at 500 mg/kg bw and scab formation with or without ulceration was seen in all rats dosed at 2000 mg/kg bw.
An area of minimal congestion of the stomach (mucosal aspect) was seen in one female rat dosed at 2000 mg/kg bw. - Other findings:
- Dermal reactions:
necrosis in all rats dosed at 500 mg/kg bw, persisting until day 12
well defined to moderate oedema in rats dosed at both levels - Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute lethal dermal dose (LD 50) of Amine KK to rats was greater than 2000 mg/kg body weight
- Executive summary:
In a GLP-compliant study similar to OECD TG 402, the test compound Amine KK (cocoalkylamine), a yellow liquid (purity 100%), was dermally applied under occlusion to Sprague-Dawley rats. At a dose level of 500 mg/kg body weight, the test material was applied undiluted (application volume 0.63 ml/kg bw), at a dose level of 2000 mg/kg bw the substance was diluted to a 40% solution (w/v) in distilled water (application volume 5 ml/kg). Compared to a regular OECD TG 402 study a reduced number of animals were used (4 instead of 5 animals/dose). There were no mortalities; hence, the LD50 is > 2000 mg/kg bw. No clinical signs were observed at 500 mg/kg bw. At 2000 mg/kg, hunched posture, abnormal gait, lethargy and decreased respiratory rate were noted. Signs of dermal reactions at the application site of both treatments were well defined to moderate oedema until days 4-5. Hard scabs, persisting to the end of the observation period, frequently prevented the assessment of oedema.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Although basically based on cross-reading, the overall weight of evidence leads to a well acceptable conclusion for non-classification of C36-alkylenediamine (Dimerdiamine).
Additional information
From the profile information it is clear that the primary alkyl amine and the dimerdiamine structures show a very comparable profile. Both consist of primary amine and large apolar alkyl chain with some level of unsaturation, making it a surface active compound when protonated. Besides aliphatic chains and the primary amines there are no other functional groups. Consequently, the possible type of chemical reaction these substances are capable of will be principally similar. The primary amines groups are positively charged at environmental and physiological conditions (pH ≤ 8).
This cationic surfactant structure has a strong influence on the fate of these substances; they have high adsorptive properties to negatively charged surfaces e.g. particular matter under environmental conditions, and negatively charged cellular membranes. The apolar tails easily dissolve in the membranes, whereas the polar head causes disruption and leakage of the membranes leading to cell damage or lysis of the cell content. As a consequence, the whole molecule will not easily pass membrane structures. Consequently, these substances mainly cause direct effects at the area of contact. In agreement to this, the QSAR Toolbox only indicates mucous membrane irritation by aliphatic amines as a mechanism of toxicity relevant to human health, which specifically refers to reported effects in the stomach upon repeated oral dosing. Also information via dermal exposures shows local effects. Studies on dermal irritation show that Octadecenylamine is corrosive to the skin, and studies on Octadecylamine show maximally irritating response with observations as indurations and desquamation, but no in-depth skin damage indicating corrosion. Also Dimerdiamine has proven to be severely irritating to skin showing to be irreversible within the 14-day observation period.
Physico-chemical data show similar tendencies between the dimerdiamine and alkyl amine mixtures as low water solubility, high calculated Pow, low vapour pressure and similar physical state. However, for the dimerdiamine these properties are even more pronounced following which they are expected to be even less bioavailable than the primary fatty amines, and consequently less prone to lead to systemic toxicity..
Oral toxicity
For the Dimerdiamine no data from an acute oral study is available.
QSARs:
- TOPKAT (Accelrys ADMET Toxicity Prediction (Extensible)) predicts an LD50 of 5.33 g/kgbw. However, it also indicates a very low validity as the substance is out of domain.
- ACD/ToxSuite (ACD Labs ToxSuite v.2.95) also predicts a low acute oral toxicity with LD50 = 3500 mg/kgbw and indicating a moderate reliability.
Cross-reading can be done to data obtained from long-chain primary alkyl amines, specifically Octadecenylamine (Oleylamine) on the basis of similarities of structure with same functional groups, properties leading to common biological activity, and common metabolic degradation. For full justification see document “Justification in support of cross-reading from primary fatty amines (PFA) to Dimerdiamine”.
Available data: In a GLP compliant OECD TG 401 study, the test material Hydrogenated tallow alkyl amine, a white granular solid (purity 95%), was orally applied to Wistar rats at a dose of 5000 mg/kg bw. The substance was applied as a 50% suspension in 1% methylcellulose (limit-test). There were no deaths; hence, the LD50 exceeded 5000 mg/kg. Clinical signs were diarrhea, piloerection, hunched posture, abnormal gait and pallor of extremities. Complete recovery from these clinical signs was observed by day 5. Body weights were initially reduced but body weight gain was not different from controls by the end of the study (day 15). No treatment-related effects were observed at necropsy. Based on the findings of this study, the acute median lethal dose (LD 50) of Hydrogenated tallow alkyl amine after a single dose to rats was greater than 5000 mg/kg body weight.
The combined available data on longer chain primary alkylamines show a general low oral toxicity.
LD50's for longer chain primary alkyl amines (oral) (from EU-RAR for primary alkyl amines, draft 2008):
1689 mg/kg (Octadecenylamine; CAS No. 112-90-3)
1900 - > 2000 mg/kg (Tallow-alkylamines; CAS No. 61790-33-8)
> 2000 mg/kg bw (Octadecylamines; CAS No. 124-30-1)
> 2000 mg/kg bw (Hydrogenated tallow-alkylamines; CAS No. 61788-45-2)
Form this information,Octadecenylamine shows the highest acute toxicity.Dimerdiamine is as much larger molecule expected to show lower absorption and therefore showing lower systemic toxicity.Form comparing repeated dose studies it seems that the dimerdiamine shows much lower toxicity compared to Octadecenylamine. A 28-day study on Octadecenylamine resulted to a NOAEL of 3.25 mg, whereas clear toxic symptoms were seen at 50 mg/kg bw/day. In a 14-day range finding 400 mg/kg bw/day led to mortality and premature sacrifice of the animals.
For Dimerdiamine an OECD 422 study resulted to a NOAEL of 50 mg/kg and only limited toxicity at 500 mg/kg bw/day, and the 14-day range finding study 1000 mg/kg led to the mortality of 2/6 animals.
In view of the large difference between acute dose levels and repeated dose levels leading to toxicity, and the much lower toxicity that dimerdiamine shows in short-term repeated dose studies, an oral LD50 > 2000 mg/kg bw can be expected for Dimerdiamine.
Inhalation:
No data available. Due to irritating/corrosive properties respiratory irritation would be in principle possible. Due to the very low vapour pressure (2.2 x10-5 hPa @ 20°C) inhalation of vapours leading to irritation of airways will not occur. Also aerosol exposures are not likely to occur in view of its main use as industrial intermediate under conditions that do not lead to aerosol formation.
No concerns are expected in view of lack of exposure.
Normally, aside from concrete evidence in humans, classification/labelling of a substance for aspiration hazard is triggered if it is a hydrocarbon and has a kinematic viscosity of 20.5 mm2/s or less, measured at 40°C. The latter can be obtained as the quotient of dynamic viscosity (in mPa•s) and density (in g/cm3). Estimation can be made for C36-alkylenediamine by calculation with a dynamic viscosity of 316 mPa•s (dynamic) at 20 °C and density of 0.885 g/cm3, resulting to a kinematic viscosity of 357 mm2/s at 20°C. It is not expected that kinematic viscosity will drop below 20.5 mm2/s at 40°C.
Dermal:
Already all the probably more toxic lower alkyl chain Coco-alkylamine shows an acute LD50 > 2000 mg/kgbw. For comparison, the acute oral LD50 for this substance was found to be LD50: 1300 mg/kg bw (from EU Annex VI report). Dimerdiamine as a twice as big molecule with even lower water solubility and higher calculated Pow compared to Octadecenylamine, and thus also to Coco-alkylamine, can be expected to have certainly a dermal LD50 > 2000 m/kgbw.Justification for selection of acute toxicity – oral endpoint
Data from cross-reading, leading to sufficient information for decision on classification. Further in vivo testing is not justified.
Justification for selection of acute toxicity – dermal endpoint
Data from cross-reading, leading to sufficient information for decision on classification. Further in vivo testing is not justified.
Justification for classification or non-classification
The evaluation of available data leads to the conclusion that for C36 -alkylenediamine, both the acute oral and acute dermal LD50 can be expected to be above 2000 mg/kg bw, Consequently, C36 -alkylenediamine does not need to be classified for acute oral or dermal toxicity for EU-CLP.
For inhalation route no data is available. However, in view of low likelihood of exposures related to very low vapour pressure no further testing is needed. .
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
